CLChristian Lewis

Christian Lewis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Christian Lewis has a total of 22 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ZNF865 (BLST) a Novel Regulator of DNA Damage and Cell Senescence in Back Pain

    by Christian Lewis, Hunter Levis, Jonah Holbrook, Jacob T. Polaski, Timothy D. Jacobsen, Josh Mizels, Molly Czachor, Sarah E. Gullbrand, Brian Diekman, James C. Iatridis, et al.

    Senescence has been shown to contribute to the progression of aging‐related diseases including degenerative disc disease (DDD). However, the mechanisms regulating senescence in the intervertebral disc (IVD) and other tissues/diseases remain poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein that regulates a wide array of genes related to protein processing, cell senescence, and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Utilizing CRISPR‐guided gene modulation, we show that ZNF865 is necessary for healthy cell function and is a critical protein in regulating senescence and DNA damage in IVD cells, with implications for a wide range of tissues and organs. We also demonstrate that downregulation of ZNF865 induces senescence in asymptomatic human nucleus pulposus (NP) cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression, and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a novel regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases.


  • Open Access

    ZNF865 (BLST) Regulates Back Pain via Cell Senescence and DNA Damage Mechanisms

    by Christian Lewis, Hunter Levis, Jonah Holbrook, Jacob T. Polaski, Timothy D. Jacobsen, Josh Mizels, Sarah E. Gullbrand, Brian Diekman, James C. Iatridis, Jason Gertz, et al.

    Senescence has been shown to contribute to the progression of aging related diseases, yet its regulation in the intervertebral disc (IVD) remains poorly understood. Recently, ZNF865 (BLST) was identified as a previously uncharacterized zinc finger protein, that regulates a wide array of genes related to protein processing, cell senescence and DNA damage repair. Here, we show that ZNF865 expression decreases with age and pathology in human and mouse IVD samples. Depletion of ZNF865 induces senescence, SASP expression and DNA damage in both human and rat healthy NP cells. Conversely, restoration in degenerative NP cells mitigates senescence, SASP expression and DNA damage, enhances ECM anabolism, and restores chromatin accessibility and gene expression to a healthy state. In vivo, CRISPRi of ZNF865 induces disc degeneration and painful behaviors. Collectively, our findings establish ZNF865 as a regulator of genome stability and a potential therapeutic target for mediating senescence/DNA damage in aging related diseases. One Sentence Summary: ZNF865 is a novel modulator of genome stability and senescence and regulates pain outcomes in the intervertebral disc via reversible senescence and DNA damage pathways.


  • Targeted CRISPR regulation of ZNF865 enhances stem cell cartilage deposition, tissue maturation rates, and mechanical properties in engineered intervertebral discs

    by Hunter Levis, Christian Lewis, Matthew Fainor, Ameerah Lawal, Elise Stockham, Jacob Weston, Niloofar Farhang, Sarah E. Gullbrand, Robby D. Bowles